Global Genital Herpes market size is expected to reach $3.15 billion by 2030 at 6%, segmented as by diagnosis, polymerase chain reaction (pcr) tests, viral culture tests, blood antibody tests (serology), antigen detection tests
Read More
Global Neuroscience market size is expected to reach $54.01 billion by 2030 at 7.6%, surging geriatric demographics fueling growth in the neuroscience market
Read More
Global Genetic Toxicology Testing market size is expected to reach $2.74 billion by 2030 at 8.4%, segmented as by in vitro, ames test, micronucleus assay, comet assay, chromosomal aberration test, cell transformation assay, other in vitro methods
Read More
Global Genetic Testing Services market size is expected to reach $34.09 billion by 2030 at 9.5%, segmented as by predictive testing, cancer predisposition testing, heart disease risk testing, neurological disorder risk testing
Read More
Global Neuroprosthetics market size is expected to reach $23.1 billion by 2030 at 14.6%, neuroprosthetics market soars as global neurological disorder and nerve injury cases surge
Read More
Global Genetic Testing market size is expected to reach $32.22 billion by 2030 at 8.9%, segmented as by type, predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomics testing, nutrigenomic testing
Read More
Global Neuroplasticity market size is expected to reach $18.48 by 2030 at 22.9%, rising burden of neurological disorders fueling the growth of the market due to increasing demand for advanced brain therapies
Read More
Global Neurotrophic Keratitis Treatment market size is expected to reach $8.48 billion by 2030 at 8.1%, segmented as by topical antibiotics, broad-spectrum antibiotics, narrow-spectrum antibiotics
Read More
The genetic engineering plant genomics market is projected to reach $90 billion by 2030, growing at 13.8% CAGR, driven by CRISPR-based breeding, climate-resilient crops, and sustainable agriculture innovation.
Read More
Global Neuromyelitis Optica Spectrum Disorder market size is expected to reach $3.76 Billion by 2030 at 8.1%, rising multiple sclerosis cases fueling the growth of the market due to improved diagnostics and increased awareness
Read More